INTS (STOCKS)
Intensity Therapeutics, Inc. Common stock
$0.404900
+0.030400 (+8.12%)
Prev close: $0.374500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Lewis H. Bender
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $24.12M
- Employees
- 16
- P/E (TTM)
- -0.59
- P/B (TTM)
- 2.54
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.06 | $-0.09 | +0.0293 | +32.81% |
|
Jun 2025 (Q2)
|
$-0.13 | $-0.20 | +0.0715 | +35.48% |
|
Mar 2025 (Q1)
|
$-0.22 | $-0.20 | -0.0211 | -10.61% |
|
Dec 2024 (Q4)
|
$-0.22 | $-0.23 | +0.0085 | +3.72% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $12.04M |
| Research and Development | $7.25M |
| Other Operating Expenses | $4.79M |
| Operating Income/Loss | -$12.04M |
| Income/Loss From Continuing Operations After Tax | -$11.74M |
| Income/Loss From Continuing Operations Before Tax | -$11.74M |
| Net Income/Loss | -$11.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.63 |
| Diluted Earnings Per Share | -$0.63 |
| Basic Average Shares | 77,248,659 |
| Diluted Average Shares | 77,248,659 |
| Assets | $9.59M |
| Current Assets | $8.19M |
| Cash | $7.10M |
| Prepaid Expenses | $1.12M |
| Noncurrent Assets | $1.40M |
| Liabilities | $2.36M |
| Current Liabilities | $2.28M |
| Accounts Payable | $1.68M |
| Wages | $15.00K |
| Other Current Liabilities | $577.00K |
| Noncurrent Liabilities | $87.00K |
| Equity | $7.22M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.22M |
| Liabilities And Equity | $9.59M |
| Net Cash Flow From Operating Activities | -$9.50M |
| Net Cash Flow From Operating Activities, Continuing | -$9.50M |
| Net Cash Flow From Investing Activities | -$4.48M |
| Net Cash Flow From Investing Activities, Continuing | -$4.48M |
| Net Cash Flow From Financing Activities | $13.79M |
| Net Cash Flow From Financing Activities, Continuing | $13.79M |
| Net Cash Flow | -$192.00K |
| Net Cash Flow, Continuing | -$192.00K |
| Comprehensive Income/Loss | -$11.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.74M |
| Other Comprehensive Income/Loss | $0.00 |